000			01985 a2200553 4500
005			20250514180510.0
264		0	_c20040304
008			200403s 0 0 eng d
022			_a0022-202X
024	7		_a10.1046/j.0022-202X.2003.22113.x _2doi
040			_aNLM _beng _cNLM
100	1		_avan der Fits, Leslie
245	0	0	_aIn psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered. _h[electronic resource]
260			_bThe Journal of investigative dermatology _cJan 2004
300			_a51-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xmetabolism
650	0	4	_aBiopsy
650	0	4	_aCell Nucleus _xmetabolism
650	0	4	_aCells, Cultured
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Expression _ximmunology
650	0	4	_aHumans
650	0	4	_aInterferon Regulatory Factor-7
650	0	4	_aInterferon-Stimulated Gene Factor 3
650	0	4	_aInterferon-Stimulated Gene Factor 3, gamma Subunit
650	0	4	_aInterferon-alpha _xmetabolism
650	0	4	_aInterferon-beta _xmetabolism
650	0	4	_aKeratinocytes _xcytology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhenotype
650	0	4	_aPsoriasis _xmetabolism
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aSTAT1 Transcription Factor
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTrans-Activators _xmetabolism
650	0	4	_aTranscription Factors _xmetabolism
700	1		_avan der Wel, Leontine I
700	1		_aLaman, Jon D
700	1		_aPrens, Errol P
700	1		_aVerschuren, Martie C M
773	0		_tThe Journal of investigative dermatology _gvol. 122 _gno. 1 _gp. 51-60
856	4	0	_uhttps://doi.org/10.1046/j.0022-202X.2003.22113.x _zAvailable from publisher's website
999			_c14684917 _d14684917